Omadacycline Tosylate Patent Expiration
Omadacycline Tosylate is Used for treating bacterial skin and skin structure infections, and community-acquired bacterial pneumonia. It was first introduced by Paratek Pharmaceuticals Inc
Omadacycline Tosylate Patents
Given below is the list of patents protecting Omadacycline Tosylate, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Nuzyra | US10383884 | 9-aminomethyl minocycline compounds and use thereof in treating community-acquired bacterial pneumonia (CABP) | Oct 31, 2037 | Paratek Pharms Inc |
| Nuzyra | US10835542 | 9-aminomethyl minocycline compounds and use thereof in treating community-acquired bacterial pneumonia (CABP) | Oct 31, 2037 | Paratek Pharms Inc |
| Nuzyra | US10111890 | 9-aminomethyl minocycline compounds and uses thereof | Aug 03, 2037 | Paratek Pharms Inc |
| Nuzyra | US9314475 | Oral and injectable formulations of tetracycline compounds | Mar 18, 2031 | Paratek Pharms Inc |
| Nuzyra | US9265740 | Minocycline compounds and methods of use thereof | Oct 24, 2030 | Paratek Pharms Inc |
| Nuzyra | US8383610 | Salts and polymorphs of 9-(2,2-dimethylpropyl-aminomethyl) minocycline | Sep 23, 2030 | Paratek Pharms Inc |
| Nuzyra | US10124014 | Minocycline compounds and methods of use thereof | Mar 05, 2029 | Paratek Pharms Inc |
| Nuzyra | US9724358 | Minocycline compounds and methods of use thereof | Mar 05, 2029 | Paratek Pharms Inc |
| Nuzyra | US7553828 | 9-aminomethyl substituted minocycline compounds | Jun 02, 2025 | Paratek Pharms Inc |
| Nuzyra | US7326696 | Amino-methyl substituted tetracycline compounds |
Sep 24, 2023
(Expired) | Paratek Pharms Inc |
| Nuzyra | US9365500 | 9-aminomethyl substituted minocycline compounds |
Jun 29, 2021
(Expired) | Paratek Pharms Inc |
Omadacycline Tosylate's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List